KCET 2021: Round 2 seat allotment results to be declared at 4 pm today; check details here

-

The Karnataka Common Entrance Test KCET 2021 round 2 seat allotment results for undergraduate courses will be announced today, 10 December by the State Examinations Authority (KEA).

Candidates should note that the KCET 2nd round seat allotment 2021 result will be released after 4:00 pm, as per an NDTV report. Those who are waiting for the results can visit the official website at https://ift.tt/2ZcSw47 soon after the announcement is made.

Applicants will be able to exercise their options against the KCET 2021 round 2 seat allotment result from 10 to 12 December.

Check steps on how to download KCET Seat Allotment 2021 Round 2:

Step 1: Visit the official website at https://ift.tt/2ZcSw47

Step 2: Search and click on the designated link that will be made available to check the KCET seat allotment result

Step 3: As the link opens, candidates need to insert login credentials correctly as required.

Step 4: After providing all details on the portal click on submit.

Step 5: Within a few seconds, the KCET seat allotment letter and result will appear on the screen

Step 6: Finally, download the result and keep a hard copy of the same for future use or reference

After the announcement of the result, those who have been shortlisted in the KCET round 2 seat allotment 2021 are requested to pay the seat acceptance fee through online mode. Furthermore, candidates are also directed to complete the document verification at the respective allotted institutes. Moreover, the last date to respond to KCET 2021 round 2 seat allotment enquiry and request is 16 December.

Meanwhile, KEA informed that options which were entered by applicants in round 1 will remain the same in the second allotment too. However, candidates are not allowed to enter another option again, as per the KEA.

The KCET was held from 28 to 30 August this year and the results for the entrance exam were out on 20 September. The first seat allotment list was released on 27 November.

For more details and information, candidates should regularly keep a check on the official website.



from Firstpost India Latest News https://ift.tt/3yfjIxi
FP Trending

Comments

Post a Comment

Popular posts from this blog

Both COVID-19 vaccine doses needed for good protection against B16172 variant

-
It’s been a concerning few weeks in the UK, with the B16172 variant first taking hold and then spreading to become dominant. This more infectious form of the virus, initially identified in India, is what we’re now going to have to live with – unless it is out-competed by another variant in the future. Worryingly, experts had predicted that B16172 might be able to escape some of the effects of vaccines, which if true would threaten to derail the UK’s plans to finish lifting restrictions from the end of June. However, Public Health England (PHE) has looked at the ability of various variants to evade immunity and says that the UK’s vaccines remain effective against the variants circulating, including B16172. On the surface, this looks like good news. But delve a bit deeper, and things get more complicated, says Paul Hunter, professor of medicine at the University of East Anglia. PHE’s research found a little drop-off in protection against B16172 among people who were fully vaccinated.
Read more

New coronavirus variant emerge in India: How should our COVID response change?

-
Image
After genome sequencing of over 10,000 COVID-19 cases in India, researchers have discovered a new variant with two new mutations which may be better at evading the immune system. In 15-20 percent of samples from the Indian state of Maharashtra (the state accounting for 62 percent of cases in the country) a new, double mutation in key areas of the virus has been detected. These are now known as the E484Q and L452R mutations. What makes the variant different? Both these mutations are concerning because they are located in a key portion of the virus – the spike protein – that it uses to penetrate human cells. Spike proteins attach via a “receptor binding domain”, meaning the virus can attach to receptors in our cells. These new mutations include changes to the spike protein that make it a “better fit” for human cells. This means the virus can gain entry more easily and multiply faster. Given what we have seen with other similar mutations , it might also make it harder for our immu
Read more

Aditya L1 Mission: Spacecraft is nearing its final phase, says ISRO chief

-
Aditya L1 spacecraft is nearing its final phase, and manoeuvres to enter the L1 point are expected to be completed by January 7, 2024, according to ISRO Chairman S Somanath. “Aditya is on the way. I think it has reached almost its final phase,” the ISRO chief told PTI on the sidelines of an event organised at VSSC to commemorate the 60th year of the First Sounding Rocket Launch. Aditya L1, India’s first space-based mission to study the Sun, was successfully launched on September 2 from the Satish Dhawan Space Centre (SDSC) in Sriharikota. The spacecraft, after travelling about 1.5 million km from Earth over 125 days, is expected to be placed in a Halo orbit around the Lagrangian point L1, considered closest to the Sun. He said that the last preparations for the spacecraft’s entry into the L1 point are currently underway incrementally.”Possibly by January 7th, the final manoeuvres will be done for entering into the L1 point,” Somanath added. Among other tasks, it will capture and tr
Read more